Matches in Wikidata for { <http://www.wikidata.org/entity/Q92430269> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92430269 description "article scientifique publié en 2019" @default.
- Q92430269 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92430269 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92430269 description "scientific article published on 01 December 2019" @default.
- Q92430269 description "wetenschappelijk artikel" @default.
- Q92430269 description "наукова стаття, опублікована 1 грудня 2019" @default.
- Q92430269 name "[Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives]" @default.
- Q92430269 name "[Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives]" @default.
- Q92430269 type Item @default.
- Q92430269 label "[Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives]" @default.
- Q92430269 label "[Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives]" @default.
- Q92430269 prefLabel "[Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives]" @default.
- Q92430269 prefLabel "[Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives]" @default.
- Q92430269 P1433 Q92430269-FAFA6E4E-473C-40AA-969A-F5542A1439CC @default.
- Q92430269 P1476 Q92430269-D2C00CC0-3022-480F-A4F5-E0F2F97A13B6 @default.
- Q92430269 P2093 Q92430269-0103F589-3C3D-45DE-9050-DAB8A52CF8E7 @default.
- Q92430269 P2093 Q92430269-0E106ED1-B0C0-46AF-B94B-715F907B717C @default.
- Q92430269 P2093 Q92430269-7DDB65AE-5B49-4D70-8FF5-FADB07000953 @default.
- Q92430269 P275 Q92430269-03bf0aee-5283-48c8-80a8-22ab476bbfb7 @default.
- Q92430269 P304 Q92430269-132021B9-C608-436A-96B2-F1560194F30C @default.
- Q92430269 P31 Q92430269-FD35AC83-F7B7-4B3F-925A-DBB54FF68326 @default.
- Q92430269 P356 Q92430269-4BC5674C-4661-4CD0-B918-267A6ADD90C1 @default.
- Q92430269 P433 Q92430269-60E4A066-EABE-4750-AE07-D5A2FE875D59 @default.
- Q92430269 P478 Q92430269-C74AE0F2-B1D7-4460-9286-23D882E01211 @default.
- Q92430269 P577 Q92430269-43B4BD9C-18EB-46FC-9439-82E087DB093B @default.
- Q92430269 P6216 Q92430269-29e6e242-2bd0-4ca3-bed5-eead33c9277e @default.
- Q92430269 P698 Q92430269-E9C04A4D-6E67-4B6F-A1B0-F07B9C128449 @default.
- Q92430269 P9108 Q92430269-EF76E41D-6E52-49C4-8862-42313A8152B1 @default.
- Q92430269 P921 Q92430269-DE14ECA3-76D5-4578-A15D-D297B432C202 @default.
- Q92430269 P356 2019197 @default.
- Q92430269 P698 31903906 @default.
- Q92430269 P1433 Q3332441 @default.
- Q92430269 P1476 "[Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives]" @default.
- Q92430269 P2093 "Claudia Pasqualini" @default.
- Q92430269 P2093 "Dominique Valteau-Couanet" @default.
- Q92430269 P2093 "Véronique Minard-Colin" @default.
- Q92430269 P275 Q20007257 @default.
- Q92430269 P304 "997-1000" @default.
- Q92430269 P31 Q13442814 @default.
- Q92430269 P356 "10.1051/MEDSCI/2019197" @default.
- Q92430269 P433 "12" @default.
- Q92430269 P478 "35" @default.
- Q92430269 P577 "2019-12-01T00:00:00Z" @default.
- Q92430269 P6216 Q50423863 @default.
- Q92430269 P698 "31903906" @default.
- Q92430269 P9108 "2019197" @default.
- Q92430269 P921 Q938205 @default.